Patents by Inventor Ernst-Juergen KANZY

Ernst-Juergen KANZY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical formulations of C1 esterase inhibitor
    Patent number: 11554156
    Abstract: The present invention relates to pharmaceutical formulations comprising the C1 esterase inhibitor (C1-INH), exhibiting a higher stability for prolonged storage and a reduced formation of aggregates of said esterase inhibitor (C1-INH) upon storage for ameliorated use in treating or preventing disorders related to kinin formation.
    Type: Grant
    Filed: July 20, 2020
    Date of Patent: January 17, 2023
    Assignee: CSL BEHRING GMBH
    Inventors: Hubert Metzner, Ernst-Juergen Kanzy
  • PHARMACEUTICAL FORMULATIONS OF C1 ESTERASE INHIBITOR
    Publication number: 20200390845
    Abstract: The present invention relates to pharmaceutical formulations comprising the C1 esterase inhibitor (C1-INH), exhibiting a higher stability for prolonged storage and a reduced formation of aggregates of said esterase inhibitor (C1-INH) upon storage for ameliorated use in treating or preventing disorders related to kinin formation.
    Type: Application
    Filed: July 20, 2020
    Publication date: December 17, 2020
    Inventors: Hubert METZNER, Ernst-Juergen KANZY
  • PHARMACEUTICAL FORMULATIONS OF C1 ESTERASE INHIBITOR
    Publication number: 20190175683
    Abstract: The present invention relates to pharmaceutical formulations comprising the C1 esterase inhibitor (C1-INH), exhibiting a higher stability for prolonged storage and a reduced formation of aggregates of said esterase inhibitor (C1-INH) upon storage for ameliorated use in treating or preventing disorders related to kinin formation.
    Type: Application
    Filed: August 4, 2017
    Publication date: June 13, 2019
    Inventors: Hubert Metzner, Ernst-Juergen Kanzy
  • PHARMACEUTICAL FORMULATIONS OF C1 ESTERASE INHIBITOR
    Publication number: 20180036394
    Abstract: The present invention relates to pharmaceutical formulations comprising the C1 esterase inhibitor (“C1-INH”), exhibiting a higher stability for prolonged storage and a reduced kinematic viscosity for ameliorated use in treating or preventing disorders related to kinin formation.
    Type: Application
    Filed: February 19, 2016
    Publication date: February 8, 2018
    Applicant: CSL BEHRING GMBH
    Inventors: Wolfram SCHAEFER, Ernst-Juergen KANZY, Hubert METZNER, Frauke MAY, Ingo PRAGST